申请人:Allergan, Inc.
公开号:US20140235613A1
公开(公告)日:2014-08-21
The present invention relates to substituted diaryl azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
本发明涉及取代二芳基氮杂环丙烷衍生物,制备方法,含有它们的药物组合物以及它们作为调节鞘氨醇-1-磷酸受体的药物的用途。